EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Pharmacologic Treatment of Acute Attacks of Episodic Migraine: A Systematic Review and Network Meta-analysis for the American College of Physicians

Gerald Gartlehner, Andreea Dobrescu, Gernot Wagner iD, Andrea Chapman iD, Emma Persad, Claus Nowak, Irma Klerings iD, Camilla Neubauer, Johanna Feyertag, Arianna Gadinger, Kylie Thaler

Annals of Internal Medicine · 2025-04 · 178 (4) · 507-524

DOI: 10.7326/annals-24-02034 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Internal Medicine, 2025-04. Verfasst von Gerald Gartlehner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cochrane Austria, American College of Physicians Center for Evidence Reviews, Department for Evidence-based Medicine and Evaluation, University of Co…. Hauptthemen laut MEDLINE: Migraine Disorders, Anti-Inflammatory Agents, Non-Steroidal, Tryptamines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Migraine is common, affecting 15% of Americans. PURPOSE: To compare benefits and harms of pharmacologic treatments for acute attacks of episodic migraine in adults and assess cost-effectiveness. DATA SOURCES: Three electronic databases searched to October 2024, gray literature, and reference lists. STUDY SELECTION: Two investigators independently selected English-language randomized trials. DATA EXTRACTION: Single reviewer data extraction with second review. Dual independent risk of bias and certainty of evidence (COE) assessment. DATA SYNTHESIS: Twenty-one head-to-head and 165 placebo-controlled trials were included in meta-analyses and network meta-analyses. Triptans were more effective than acetaminophen (low COE) and nonsteroidal anti-inflammatory drugs (NSAIDs) (high COE) for pain outcomes at 2 hours and pain freedom up to 48 hours. Triptan and acetaminophen combinations were more effective than acetaminophen alone (moderate COE) for pain outcomes at 2 hours and pain freedom up to 48 hours but not more than triptans alone (low COE). Triptan and NSAID combinations were more effective for pain outcomes at 2 hours and pain freedom up to 48 hours compared with acetaminophen (low COE), gepants (low COE), NSAIDs (high COE), and triptan monotherapy (moderate COE). Triptan regimens, however, often had a higher risk for adverse events. One study found triptans more cost-effective than ditans and gepants. LIMITATIONS: Harms assessment was limited to randomized trials. Many comparisons lacked sufficient evidence to draw conclusions. CONCLUSION: Triptans and combinations of triptans were more effective than NSAID and acetaminophen alone. PRIMARY FUNDING SOURCE: American College of Physicians. (PROSPERO: CRD42023441146).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersAnti-Inflammatory Agents, Non-SteroidalTryptaminesHumansAcetaminophenAcute DiseaseCost-Benefit AnalysisDrug Therapy, CombinationRandomized Controlled Trials as Topic

Substanzen

Anti-Inflammatory Agents, Non-SteroidalAcetaminophenTryptamines

Autor:innen und Institutionen

  • Cochrane Austria, American College of Physicians Center for Evidence Reviews, Department for Evidence-based Medicine and Evaluation, University of Continuing Education Krems, Krems, Austria, and RTI International, Cente…
  • Cochrane Austria, American College of Physicians Center for Evidence Reviews, Department for Evidence-based Medicine and Evaluation, University of Continuing Education Krems, Krems, Austria (A.D., G.W., A.C., E.P., C.No…
  • Cochrane Austria, American College of Physicians Center for Evidence Reviews, Department for Evidence-based Medicine and Evaluation, University of Continuing Education Krems, and Karl Landsteiner University of Health Sc…

ORCID-Profile: Gernot Wagner, Andrea Chapman, Irma Klerings

Zitieren

APA

Gartlehner, G., Dobrescu, A., Wagner, G., Chapman, A., Persad, E., Nowak, C., Klerings, I., Neubauer, C., Feyertag, J., Gadinger, A., & Thaler, K. (2025). Pharmacologic Treatment of Acute Attacks of Episodic Migraine: A Systematic Review and Network Meta-analysis for the American College of Physicians. Annals of Internal Medicine, 178(4), 507-524. https://doi.org/10.7326/annals-24-02034

Vancouver

Gartlehner G, Dobrescu A, Wagner G, Chapman A, Persad E, Nowak C, et al. Pharmacologic Treatment of Acute Attacks of Episodic Migraine: A Systematic Review and Network Meta-analysis for the American College of Physicians. Annals of Internal Medicine. 2025;178(4):507-524. doi:10.7326/annals-24-02034

BibTeX
@article{Gartlehner2025,
  author = {Gartlehner, Gerald and Dobrescu, Andreea and Wagner, Gernot and Chapman, Andrea and Persad, Emma and Nowak, Claus and Klerings, Irma and Neubauer, Camilla and Feyertag, Johanna and Gadinger, Arianna and Thaler, Kylie},
  title = {Pharmacologic Treatment of Acute Attacks of Episodic Migraine: A Systematic Review and Network Meta-analysis for the American College of Physicians},
  journal = {Annals of Internal Medicine},
  year = {2025},
  volume = {178},
  number = {4},
  pages = {507--524},
  doi = {10.7326/annals-24-02034}
}
Kostenlos starten →